Closing the regulatory regress: GMP accreditation in stem cell laboratories.
Sociol Health Illn
; 35(3): 345-60, 2013 Mar.
Article
em En
| MEDLINE
| ID: mdl-22882658
ABSTRACT
Contemporary biomedical research is conducted amidst regimes of national and transnational regulation. Regulation, like rules generally, cannot specify all the practicalities of their application. Regulations for biomedical research impose considerable constraints on laboratories and others. In principle, there is a never-ending regress whereby scientists have to provide increasingly more guarantees that protocols have been followed, standards reached and maintained, and rules adhered to. In practice, regulatory regress is not the actual outcome, as actors find ways of establishing closure for all practical purposes. Based on ethnographic case studies of two sites of biomedical work--the UK Stem Cell Bank and an anonymous laboratory working with primary human foetal material--this article documents the possibility of regulatory regress and strategies aimed at its closure.
Palavras-chave
Texto completo:
1
Base de dados:
MEDLINE
Assunto principal:
Bancos de Espécimes Biológicos
/
Pesquisa com Células-Tronco
/
Acreditação
/
Laboratórios
Tipo de estudo:
Guideline
/
Qualitative_research
Limite:
Humans
País como assunto:
Europa
Idioma:
En
Ano de publicação:
2013
Tipo de documento:
Article